Iht Wealth Management, LLC Ionis Pharmaceuticals Inc Transaction History

Iht Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $249,811 - $338,754	-7,878 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $1,494 - $1,852	-50 Reduced 0.63%	7,878 $292,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $203,036 - $278,272	7,928 New	7,928 $241,000
Q2 2018 Aug 13, 2018	SELL	$40.53 - $50.7 $4,053 - $5,070	-100 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $3,219 - $4,120	-64 Reduced 39.02%	100 $5,000
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $7,471 - $9,769	164	164 $9,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.87B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.